Skip to content
Oncology Research Hub

Minnesota

Cancer clinical trials in Minnesota

355 cancer studies are recruiting participants at sites in 50 cities across Minnesota as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Minnesota city with a recruiting study

By research area: Breast Cancer (96), Lung Cancer (84), Lymphoma (80), Prostate Cancer (43), Pancreatic Cancer (34), Melanoma (18).

Rochester (210), Minneapolis (130), Saint Paul (64), Saint Louis Park (59), Duluth (49), Coon Rapids (47), Edina (42), Deer River (35), Hibbing (35), Sandstone (35), Virginia (35), Maplewood (30), Brainerd (29), Woodbury (29), Bemidji (28), Burnsville (27), Maple Grove (25), Shakopee (22), Waconia (22), Robbinsdale (20), Saint Cloud (19), Stillwater (18), Monticello (14), Detroit Lakes (13), New Ulm (13), Willmar (13), Fosston (11), Princeton (11), Thief River Falls (11), Worthington (11), Chaska (10), Wyoming (10), Park Rapids (9), Aitkin (8), Albert Lea (7), Baxter (7), Cambridge (7), Crosslake (7), Ely (7), International Falls (7), Mankato (7), Moose Lake (7), Pequot Lakes (7), Pine River (7), Staples (7), Fridley (5), Marshall (5), Fergus Falls (1), Plymouth (1), Springfield (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Minnesota

Basic details from each study's public record (the 12 most recently updated of 355). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    LeonaBio
    Recruiting in
    Rochester
    Registry record
    NCT05696626 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Saint Louis Park
    Registry record
    NCT07488676 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Minnesota on ClinicalTrials.gov.

Lung cancer: recently updated in Minnesota

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Rochester
    Registry record
    NCT07277413 · updated
  2. SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Full-Life Technologies UK Limited
    Recruiting in
    Minneapolis
    Registry record
    NCT07873450 · updated
  3. A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Rochester
    Registry record
    NCT07063745 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Minnesota on ClinicalTrials.gov.

Prostate cancer: recently updated in Minnesota

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Minneapolis
    Registry record
    NCT04038502 · updated
  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Burnsville · Chaska · Coon Rapids · and 14 more U.S. locations
    Registry record
    NCT04423211 · updated
  3. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Marshall · Minneapolis
    Registry record
    NCT06136624 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Minnesota on ClinicalTrials.gov.

Melanoma: recently updated in Minnesota

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Bemidji · Thief River Falls
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Minnesota on ClinicalTrials.gov.

Lymphoma: recently updated in Minnesota

  1. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Rochester
    Registry record
    NCT06724237 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Minnesota on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Minnesota

  1. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Recruiting in
    Maple Grove
    Registry record
    NCT07522073 · updated
  2. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Rochester
    Registry record
    NCT07644559 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Minnesota on ClinicalTrials.gov.

Ask about studies in Minnesota

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call